Equity Research, Broker Reports, and media content on BTG

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about BTG
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard


Company Profile

Profile:BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.
  • Personnel
  • Duncan Kennedy, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on BTG. We currently have 36 research reports from 6 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 553/784p
  • Daily Volume: N/A
  • Daily Liquidity: 0.0%
  • # Shares: 0m
  • Market Cap: £2,624m
  • Latest PE (hist): 22.95
  • Div Yield:
Date Source Announcement
19Aug19 09:21 RNS Scheme becomes Effective
19Aug19 07:30 RNS Temporary Suspension BTG PLC
16Aug19 15:40 RNS Director/PDMR Shareholding
15Aug19 17:27 RNS Holding(s) in Company
15Aug19 15:23 RNS Court sanction of the Scheme
14Aug19 17:30 RNS BTG
14Aug19 17:11 RNS Holding(s) in Company
  • Frequency of research reports


  • Research reports on


  • Providers covering